跳至主要内容
临床试验/NCT03566992
NCT03566992Unknown不适用

Effect of Location of Feeding on Glycemic Control in Critically Ill Patients (ELF)

Winchester Medical Center2 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
170
试验地点
2
主要终点
Nasoenteric tube placement

研究概览

简要总结

The purpose of this study is to investigate the effect of location of feeding on glycemic control in critically ill patients.

The investigators hypothesize that glycemic control in critically ill patients who receive enteral nutrition through postpyloric location (beyond stomach) will have better glycemic control compared to critically ill patients fed gastrically.

详细描述

Randomization will happen after initial stabilization phase which may last up to 24 hours till when patient may or may not have an enteric access. If enteral access is gained and patient is screened in for the study using inclusion and exclusion criteria, a consent shall be obtained for enrollment. The tube may be continued to be used if randomized in group A. If patient is randomized to group B, a postpyloric placement will be achieved.

Randomization using computer software and a unique identification number will be assigned to every intubated patients who may need mechanical ventilation or tube feed for more than 48 hours.

Randomization will be considered incomplete and the case will be excluded if the process of assigning group, confirmation of placement of appropriate group specific tube and nutrition is not initiated within 24 hours.

If patient is randomized into group A, a bedside RN or the intensivist will place a Salem Sump gastric tube. A nutrition consult for tube feed will be obtained. Confirmation of gastric placement and not a postpyloric placement will be based on the length of the orogastric/nasogastric tube and a standard chest radiograph obtained routinely after intubation. The NG or OG tube should not be more than 65 cm in most cases to prevent it from migrating into the postpyloric location. A standard enteral tube feed formula will be initiated. Blood sugars checked via basic metabolic (at least daily) panel and point-of-care glucose tests (at least every 6 hours) will be obtained. Data collection and Salem Sump placement will be confirmed by the studying team and will not be known to the RD prescribing the nutrition.

If a patient is randomized into group B, a trained RN or RD will place the small-bore feeding feeding tube in the postpyloric position. The effort will be to assure jejunal placement, but postpyloric placement should be sufficient. If for some reason, the small-bore tube cannot be passed beyond pylorus, then sufficient length will be left in IRB the stomach and the case will be noted to have not had the postpyloric placement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (18 years or above) patients admitted in the critical care unit on mechanical ventilation for at least 48 hours
  • Orders for tube feeding

排除标准

  • Intubated for less than 48 hours (suspected insufficient time for the role of feeding mode to affect glycemic control)
  • Patients not being fed (such as DKA, GI bleed, obstruction, ileus, etc)
  • Pre-existing PEG/PEJ tubes
  • Surgically altered upper and middle GI tract such as partial gastrectomy, gastric bypass surgeries etc. (patients with ileostomy and colostomy may still be included if the enteral route is used for nutrition)
  • No informed consent
  • Primary attending finds medical necessity to have a specific type of tube preventing randomization

研究组 & 干预措施

Gastric Tube Placement

Active Comparator

Nasoenteric tube placed in the stomach.

干预措施: Gastric (Procedure)

Small bowel

Experimental

Nasoenteric tube placed in the small bowel.

干预措施: Gastric (Procedure)

结局指标

主要结局

Nasoenteric tube placement

时间窗: Intubated patients >48 hours and up to 7 days.

Investigate the effect of location of feeding on glycemic control

次要结局

未报告次要终点

研究者

发起方
Winchester Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Padmaraj Duvvuri

Principal Investigator, Critical Care Physician

Winchester Medical Center

研究点 (2)

Loading locations...

相似试验